SUMMARY
Adequate volume replacement is known to be a therapeutic cornerstone in the perioperative period. Guarantee or/of restoration of tissue perfusion represents a particular challenge in patients with circulatory abnormalities. Besides the natural colloid albumin and crystalloids, synthetic colloids such as gelatins, dextrans or hydroxethyl starch (HES) preparations are used in this situation. Meta‐analyses have shown conflicting results and appear to be more confusing than helpful in evaluating the ‘ideal’ kind of solution for volume therapy. The principles of volume therapy in the surgical and cardiac surgery patient are presented and the different synthetic colloids as plasma substitutes are reviewed.